|
|
||||||||
1 Department of Public Health, Hamamatsu University School of Medicine, Shizuoka 431-31,
2 Immunology Division, Jichi Medical School, Tochigi 329-04,
3 Institute of Applied Biochemistry, University of Tsukuba, Ibaraki 305,
4 Japanese Red Cross Blood Center, Saitama 388,
5 First Department of Internal Medicine, Yamanashi Medical College, Yamanashi 429-38,
6 Department of Hygiene, Hiroshima University School of Medicine, Hiroshima 734
and7 Institute of Immunology, Koraku 1-1-10, Bunkyo-ku, Tokyo 112, Japan
An ELISA was used to detect a protein derived from the core gene of the hepatitis C virus (HCV) in human plasma. The solid phase antibody in the assay was a murine monoclonal antibody against a synthetic peptide deduced from the putative core gene of HCV (residues 39 to 74). An enzyme-labelled affinity-purified human antibody directed at another region within the HCV core (residues 5 to 23) was the second antibody tracer. The ELISA had a sensitivity capable of detecting a few ng/ml of the HCV core polypeptide expressed in Escherichia coli. Core antigen activity in plasma of infected hosts was detected after treatment of HCV RNA-rich fractions from buoyant density centrifugation with the detergent Tween 80. There was a direct correlation between core antigen ELISA values of a plasma fraction and intensities of polymerase chain reaction signals for HCV RNA. These observations are consistent with the proposal that the N-terminal sequence of the predicted polyprotein of HCV is a nucleocapsid protein, and that improved core antigen assays may correlate with viraemia.
Received 29 August 1991;
accepted 29 October 1991.
This article has been cited by other articles:
![]() |
M. Takahashi, H. Saito, M. Higashimoto, K. Atsukawa, and H. Ishii Benefit of Hepatitis C Virus Core Antigen Assay in Prediction of Therapeutic Response to Interferon and Ribavirin Combination Therapy J. Clin. Microbiol., January 1, 2005; 43(1): 186 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maillard, K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, and A. Budkowska Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients J. Virol., September 1, 2001; 75(17): 8240 - 8250. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aoyagi, C. Ohue, K. Iida, T. Kimura, E. Tanaka, K. Kiyosawa, and S. Yagi Development of a Simple and Highly Sensitive Enzyme Immunoassay for Hepatitis C Virus Core Antigen J. Clin. Microbiol., June 1, 1999; 37(6): 1802 - 1808. [Abstract] [Full Text] |
||||
![]() |
H. Ohto, S. Terazawa, N. Sasaki, N. Sasaki, K. Hino, C. Ishiwata, M. Kako, N. Ujiie, C. Endo, A. Matsui, et al. Transmission of Hepatitis C Virus from Mothers to Infants N. Engl. J. Med., March 17, 1994; 330(11): 744 - 750. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |